Medality Medical Commences Clinical Trial for Type 2 Diabetes
MIDLAND PARK, NJ – September 16, 2019 – Medality Medical LLC (“Medality” or the “Company”), a U.S.-based medical technology company, announced that it has received Institutional Review Board (IRB) approval from the University of Texas Health Science Center at San Antonio to commence human trials. Patient recruitment is currently underway for the first in-human clinical trial […]
Medality Medical Commences Clinical Trial for Type 2 Diabetes Read More »